The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Guria K.G.

Chazov National Medical Research Center of Cardiology

Avtaeva Y.N.

Chazov National Medical Research Center of Cardiology

Melnikov I.S.

Chazov National Medical Research Center of Cardiology;
Institute of Biomedical Problems

Vdovin V.M.

National Medical Research Center of Hematology

Momot A.P.

National Medical Research Center of Hematology

Saburova O.S.

Chazov National Medical Research Center of Cardiology

Shtelmakh V.E.

Chazov National Medical Research Center of Cardiology

Kozlov S.G.

Chazov National Medical Research Center of Cardiology

Okhota S.D.

Chazov National Medical Research Center of Cardiology

Prokofieva L.V.

Chazov National Medical Research Center of Cardiology

Gabbasov Z.A.

Chazov National Medical Research Center of Cardiology

Fibrin monomer in diagnosis of cardiovascular diseases

Authors:

Guria K.G., Avtaeva Y.N., Melnikov I.S., Vdovin V.M., Momot A.P., Saburova O.S., Shtelmakh V.E., Kozlov S.G., Okhota S.D., Prokofieva L.V., Gabbasov Z.A.

More about the authors

Journal: Russian Cardiology Bulletin. 2024;19(4‑2): 113‑120

DOI: 10.17116/Cardiobulletin202419042113

Read: 1404 times

Download PDF (RU)
Contact the author
Table of contents

FIBRIN MONOMER IN DIAGNOSIS OF CARDIOVASCULAR DISEASES
FIBRIN MONOMER IN DIAGNOSIS OF CARDIOVASCULAR DISEASES

To cite this article:

Guria KG, Avtaeva YN, Melnikov IS, et al. . Fibrin monomer in diagnosis of cardiovascular diseases. Russian Cardiology Bulletin. 2024;19(4‑2):113‑120. (In Russ.)
https://doi.org/10.17116/Cardiobulletin202419042113

Подписка 2026 Кардиологический вестник (Russian Cardiology Bulletin)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Frailty in patients with atrial fibrillation: diagnosis, mana­gement, prevention and influence on prognosis. Russian Cardiology Bulletin. 2025;(1):5-12
Prevalence and role of elevated serum lipo­protein(a) in patients with myocardial infa­rction acco­rding to the Russian regi­ster of acute myocardial infa­rction REGION-MI. Russian Cardiology Bulletin. 2025;(1):39-48
Signs of high embo­lic risk in iliocaval floating thro­mbi. Piro­gov Russian Journal of Surgery. 2025;(3):56-62
Prevalence of cere­brovascular diseases risk factors acco­rding to the cohort survey data in Bishkek, Kyrgyz Repu­blic. Russian Journal of Preventive Medi­cine. 2025;(3):34-39
Asthenia in the acute period of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):5-10
Effe­ctiveness of comprehensive reha­bilitation of patients after a stroke in terms of changes in clinical and functional characteristics. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):11-16
Methods for dete­rmining the extent of ischemic changes in brain matter in the prognosis of clinical outcome after successful thro­mboextraction. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):17-27
Confirmation of the competitive vali­dity of the Russian Apha­siological Test, a new standardized tool for the diagnosis of apha­sia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):28-34
Cere­brolysin and the opti­mal timing of anti­coagulation resu­mption in stroke: combined post hoc survival analysis of the CERE­HETIS trial. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):77-93
Contemporary aspe­cts of brain protection in aortic arch surgery. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):164-173
Abstract:

This review discusses current issues of fibrin monomer as a marker for diagnosing cardiovascular diseases. The authors analyzed available literature data on the feasibility of fibrin monomer for assessing the risks of thrombotic complications, their severity and pre-thrombotic conditions. In the context of various cardiovascular diseases, fibrin monomer concentration allows identifying early stages of DIC syndrome and assessing its severity, differentiating the type of strokes (embolic or not), assessing the risks of postoperative deep vein thrombosis and thromboembolic complications. The shortcomings of current methods for analysis of fibrin monomer (insufficient standardization and no universal threshold values) are also considered. The authors analyze the prospects for further development of more advanced methods for analysis of fibrin monomer concentrations and their subsequent introduction into clinical practice.

Keywords:

fibrin monomer
myocardial infarction
stroke
atrial fibrillation
pulmonary embolism
deep vein thrombosis
disseminated intravascular coagulation

Authors:

Guria K.G.

Chazov National Medical Research Center of Cardiology

Avtaeva Y.N.

Chazov National Medical Research Center of Cardiology

Melnikov I.S.

Chazov National Medical Research Center of Cardiology;
Institute of Biomedical Problems

Vdovin V.M.

National Medical Research Center of Hematology

Momot A.P.

National Medical Research Center of Hematology

Saburova O.S.

Chazov National Medical Research Center of Cardiology

Shtelmakh V.E.

Chazov National Medical Research Center of Cardiology

Kozlov S.G.

Chazov National Medical Research Center of Cardiology

Okhota S.D.

Chazov National Medical Research Center of Cardiology

Prokofieva L.V.

Chazov National Medical Research Center of Cardiology

Gabbasov Z.A.

Chazov National Medical Research Center of Cardiology

Received:

11.11.2024

Accepted:

20.11.2024

Close metadata

References:

  1. Dempfle CE. The use of soluble fibrin in evaluating the acute and chronic hypercoagulable state. Thromb Haemost. 1999;82(2):673-683.  https://doi.org/10.1055/s-0037-1615896
  2. Wada H, Sakuragawa N. Are fibrin-related markers useful for the diagnosis of thrombosis? Semin Thromb Hemost. 2008;34(1):33-38.  https://doi.org/10.1055/s-2008-1066021
  3. Kontny F, Dempfle CE, Abildgaard U. Fibrin monomer antigen. A novel marker of mortality in acute myocardial infarction. Eur Heart J. 1999; 20(11):808-812.  https://doi.org/10.1053/euhj.1998.1454
  4. Yoshihisa A, Sato Y, Kimishima Y, et al. Soluble fibrin monomer complex is associated with cardio- and cerebrovascular events in patients with heart failure. IJC Hear Vasc. 2021;32:100697. https://doi.org/10.1016/j.ijcha.2020.100697
  5. Brügger-Andersen T, Hetland Ø, Pönitz V, Grundt H, Nilsen DWT. The effect of primary percutaneous coronary intervention as compared to tenecteplase on myeloperoxidase, pregnancy-associated plasma protein A, soluble fibrin and D-dimer in acute myocardial infarction. Thromb Res. 2007;119(4):415-421.  https://doi.org/10.1016/j.thromres.2006.03.009
  6. Ieko M, Naito S, Yoshida M, et al. Plasma soluble fibrin monomer complex as a marker of coronary thrombotic events in patients with acute myocardial infarction. Tohoku J Exp Med. 2009;219(1):25-31.  https://doi.org/10.1620/tjem.219.25
  7. Elged AAE, El-Gamal RA, Bastawy S, Saeed M. Soluble fibrin monomer complex assay enhances early and accurate diagnosis of acute myocardial infarction. Int J Clin Exp Pathol. 2016;9(5):5801-5809.
  8. Koretsune Y, Yamashita T, Akao M, et al. Coagulation Biomarkers and Clinical Outcomes in Elderly Patients With Nonvalvular Atrial Fibrillation: ANAFIE Subcohort Study. JACC Asia. 2023;3(4):595-607.  https://doi.org/10.1016/j.jacasi.2023.06.004
  9. Rivera-Caravaca JM, Roldán V, Romera M, et al. Soluble Fibrin Monomer Complex and Prediction of Cardiovascular Events in Atrial Fibrillation: The Observational Murcia Atrial Fibrillation Project. J Gen Intern Med. 2018;33(6):847-854.  https://doi.org/10.1007/s11606-017-4279-4
  10. Sato M, Suzuki A, Nagata K, Uchiyama S. Increased von Willebrand factor in acute stroke patients with atrial fibrillation. J Stroke Cerebrovasc Dis. 2006;15(1):1-7.  https://doi.org/10.1016/j.jstrokecerebrovasdis.2005.09.005
  11. Sadanaga T, Mitamura H. Soluble fibrin monomer complex levels during oral anticoagulant therapy do not predict subsequent thromboembolic events in patients with permanent atrial fibrillation. Int J Cardiol. 2013;168(1):578-580.  https://doi.org/10.1016/j.ijcard.2013.01.259
  12. Fassbender K, Dempfle CE, Mielke O, et al. Changes in coagulation and fibrinolysis markers in acute ischemic stroke treated with recombinant tissue plasminogen activator. Stroke. 1999;10(30):2101-2104.
  13. Tamura H, Hirono O, Okuyama H, et al. Elevated serum fibrin-monomer levels are associated with high long-term cerebrovascular event rates in acute ischemic stroke patients. Circ J. 2007;71(10):1573-1579. https://doi.org/10.1253/circj.71.1573
  14. Okuyama H, Hirono O, Liu L, Takeishi Y, Kayama T, Kubota I. Higher levels of serum fibrin-monomer reflect hypercoagulable state and thrombus formation in the left atrial appendage in patients with acute ischemic stroke. Circ J. 2006;70(8):971-976.  https://doi.org/10.1253/circj.70.971
  15. Hirano K, Takashima S, Dougu N, et al. Study of hemostatic biomarkers in acute ischemic stroke by clinical subtype. J Stroke Cerebrovasc Dis. 2012;21(5):404-410.  https://doi.org/10.1016/j.jstrokecerebrovasdis.2011.08.013
  16. Wu D, Liu Y. FM Combined With NIHSS Score Contributes to Early AIS Diagnosis and Differential Diagnosis of Cardiogenic and Non-Cardiogenic AIS. Clin Appl Thromb. 2021;27.  https://doi.org/10.1177/10760296211000129
  17. Komarov AL, Kropacheva ES, Panchenko EP. Pulmonary Artery Thromboembolism. Study guide. — M.; 2023 (In Russ.)
  18. Reber G, Bounameaux H, Perrier A, De Moerloose P. Performances of the fibrin monomer test for the exclusion of pulmonary embolism in symptomatic outpatients. Thromb Haemost. 1999;81(2):221-223.  https://doi.org/10.1055/s-0037-1614446
  19. Schutgens REG, Haas FJLM, Agterof MJ, Vos M, Biesma DH. Therole of fibrin monomers in optimizing the diagnosticwork-up of deep vein thrombosis. Thromb Haemost. 2007;97(5):807-813.  https://doi.org/10.1160/TH06-04-0222
  20. Elias A, Cazanave G, Nguyen F, Elias M, Bongard V, Cambus JP. Comparison of the diagnostic performance of three soluble fibrin monomer tests and a D-dimer assay in patients with clinically suspected deep vein thrombosis of the lower limbs. Haematologica. 2004;89(4):499-501. 
  21. Dopsaj V, Bogavac-Stanojevic N, Vasic D, et al. Excluding deep venous thrombosis in symptomatic outpatients: Is fibrin monomer aid to D-dimer analysis? Blood Coagul Fibrinolysis. 2009;20(7):546-551.  https://doi.org/10.1097/MBC.0b013e32832e0605
  22. Takeshima M, Ishikawa H, Ogasawara M, et al. The usefulness of the combination of d-dimer and soluble fibrin monomer complex for diagnosis of venous thromboembolism in psychiatric practice: a prospective study. Vasc Health Risk Manag. 2021;17(April):239-246.  https://doi.org/10.2147/VHRM.S307689
  23. Vogel G, Dempfle CE, Spannagl M, Leskopf W. The value of quantitative fibrin monomer determination in the early diagnosis of postoperative deep vein thrombosis. Thromb Res. 1996;81(2):241-251.  https://doi.org/10.1016/0049-3848(95)00241-3
  24. Akagawa M, Kijima H, Kimura Y, et al. Fibrin monomer complex on postoperative day 1 is correlated with the volume of deep vein thrombosis after knee surgery. J Exp Orthop. 2022;9(1). https://doi.org/10.1186/s40634-022-00482-y
  25. Hasegawa M, Wada H, Miyazaki S, et al. The evaluation of fibrin-related markers for diagnosing or predicting acute or subclinical venous thromboembolism in patients undergoing major Orthopedic Surgery. Clin Appl Thromb. 2018;24(1):107-114.  https://doi.org/10.1177/1076029616674824
  26. Ezaki M, Wada H, Ichikawa Y, et al. Plasma Soluble Fibrin Is Useful for the Diagnosis of Thrombotic Diseases. J Clin Med. 2023;12(7):2597. https://doi.org/10.3390/jcm12072597
  27. Mitani G, Takagaki T, Hamahashi K, et al. Associations between venous thromboembolism onset, D-dimer, and soluble fibrin monomer complex after total knee arthroplasty. J Orthop Surg Res. 2015;10(1):1-8.  https://doi.org/10.1186/s13018-015-0315-4
  28. Yoshioka K, Kitajima I, Kabata T, et al. Venous thromboembolism after spine surgery: Changes of the fibrin monomer complex and D-dimer level during the perioperative period — Clinical article. J Neurosurg Spine. 2010;13(5):594-599.  https://doi.org/10.3171/2010.5.SPINE09883
  29. Kochi M, Shimomura M, Hinoi T, et al. Possible role of soluble fibrin monomer complex after gastroenterological surgery. World J Gastroenterol. 2017;23(12):2209-2216. https://doi.org/10.3748/wjg.v23.i12.2209
  30. Hayashi H, Shimizu A, Kubota K, et al. Asymptomatic Venous Thromboembolism After Hepatobiliary–Pancreatic Surgery: Early Detection Using D-dimer and Soluble Fibrin Monomer Complex Levels. Ann Gastroenterol Surg. 2022;6(1):109-118.  https://doi.org/10.1002/ags3.12495
  31. Vorobyev AI, Vasiliev SA, Gorodetsky VM. Syndrome of acute disseminated blood coagulation in clinical practice. Klinicheskaya Laboratornaya Diagnostika. 1997;5:12-14. (In Russ.)
  32. Horan JT, Francis CW. Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation. Semin Thromb Hemost. 2001;27(6):657-666.  https://doi.org/10.1055/s-2001-18870
  33. Wada H, Sase T, Matsumoto T, et al. Increased soluble fibrin in plasma of patients with disseminated intravascular coagulation. Clin Appl Thromb. 2003;9(3):233-240.  https://doi.org/10.1177/107602960300900308
  34. Wada H, Wakita Y, Nakase T, et al. Increased plasma-soluble fibrin monomer levels in patients with disseminated intravascular coagulation. Am J Hematol. 1996;51(4):255-260.  https://doi.org/10.1002/(SICI)1096-8652(199604)51:4<255::AID-AJH1>3.0.CO;2-V
  35. Singh N, Pati HP, Tyagi S, Upadhyay AD, Saxena R. Evaluation of the Diagnostic Performance of Fibrin Monomer in Comparison to d-Dimer in Patients with Overt and Nonovert Disseminated Intravascular Coagulation. Clin Appl Thromb. 2017;23(5):460-465.  https://doi.org/10.1177/1076029615615959
  36. Zheng X, Chen S, Zhang F, Ye M, Chen J, Zhang S. Use of fibrin monomer and D-Dimer in assessing overt and nonovert disseminated intravascular coagulation. Blood Coagul Fibrinolysis. 2021;32(4):248-252.  https://doi.org/10.1097/MBC.0000000000001025
  37. Dempfle CE, Wurst M, Smolinski M, et al. Use of soluble fibrin antigen instead of D-dimer as fibrin-related marker may enhance the prognostic power of the ISTH overt DIC score. Thromb Haemost. 2004;91(4):812-818.  https://doi.org/10.1160/th03-09-0577
  38. Okamoto K, Wada H, Hatada T, et al. Frequency and hemostatic abnormalities in pre-DIC patients. Thromb Res. 2010;126(1):74-78.  https://doi.org/10.1016/j.thromres.2010.03.017
  39. Park KJ, Kwon EH, Kim HJ, Kim SH. Evaluation of the diagnostic performance of fibrin monomer in disseminated intravascular coagulation. Korean J Lab Med. 2011;31(3):143-147.  https://doi.org/10.3343/kjlm.2011.31.3.143
  40. Refaai MA, Riley P, Mardovina T, Bell PD. The Clinical Significance of Fibrin Monomers. Thromb Haemost. 2018;118(11):1856-1866. https://doi.org/10.1055/s-0038-1673684.
  41. Godzoeva A.O., Zazerskaya I.E., Vlasov V.S., Vavilova T.V., Gorelova I.V., Kustarov V.N., Zhambalova T.V. Fibrin monomer and D-dimer in infertile women undergoing assisted reproductive technology. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2020; 9: 73-81 (in Russ.) https://doi.org/10.18565/aig.2020.9.73-81
  42. Vlasov VS, Godzoeva AO, Kudryashova OA, Kozina OV, Belyaeva OA, Vavilova TV. Fibrin monomer in the practice of laboratory assessment of hypercoagulable state in pregnancy. Thrombos, hemostas and rheologiya. 2022;1:37-44 (In Russ.)].
  43. Iwamoto T, Hatayama Y, Namba H, et al. Fibrin monomer complex as a potential thrombosis marker related to venous thromboembolism risk in pregnant women. Ann Clin Biochem. 2023;60(4):279-285.  https://doi.org/10.1177/00045632231160667
  44. Hardy M, Michaux I, Bulpa P, et al. Serial fibrin monomer and D-dimer plasma levels measurements can capture thrombotic complications in critically ill COVID-19 patients: A prospective observational study. Thromb Res. 2023;221:69-72.  https://doi.org/10.1016/j.thromres.2022.11.026
  45. Smadja DM, Gendron N, Philippe A, et al. Fibrin monomers evaluation during hospitalization for COVID-19 is a predictive marker of in-hospital mortality. Front Cardiovasc Med. 2023;10.  https://doi.org/10.3389/fcvm.2023.1001530
  46. Kawame C, Kasai H, Shiohira S, et al. Role of Fibrin Monomer Complex in Coronavirus Disease 2019 for Venous Thromboembolism and the Prognosis. Intern Med. 2023;62(20):2941-2948. https://doi.org/10.2169/internalmedicine.1322-22
  47. Vdovin VM, Momot AP, Orekhov DA, Krasyukova VO, Shakhmatov II, Lycheva NA, Momot DA, Chernus VE, Terjaev VV. Posttraumatic bleeding reduction by systemic administration of fibrin monomer in thrombolytic therapy. Patologiya krovoobrashcheniya i kardiokhirurgiya. 2020;24(1):78-86. (In Russ.) https://doi.org/10.21688/1681-3472-2020-1-78-86
  48. Vdovin VM, Momot AP, Shakhmatov II, Bobrov IP, Orekhov DA, Terjaev VV, Chernus’ VE, Kuznetsova DV. Effects of tranexamic acid and exogenous fibrin monomer on the liver injury area and systemic circulation in pharmacological suppression of platelet function in an experiment. Kazan Medical Journal. 2021; 102 (5): 642-653. (In Russ.) https://doi.org/10.17816/KMJ2021-642
  49. Vdovin VM, Shakhmatov II, Bobrov IP, Orekhov DA, Teryayev VV, Chernus’ VE, Momot AP. Morphologic, Hemostasiologic and Hemostatic Aspects of Systemic Application of Exogenous Fibrin Monomer in Model of Posttraumatic Bleeding with Underlying Intake of Warfarin. I. P. Pavlov Russian Medical Biological Herald. 2023;31(1):5-18. (In Russ.) https://doi.org/10.17816/PAVLOVJ108736
  50. Hoshino K, Muranishi K, Kawano Y, et al. Soluble fibrin is a useful marker for predicting extracorporeal membrane oxygenation circuit exchange because of circuit clots. J Artif Organs. 2018;21(2):196-200.  https://doi.org/10.1007/s10047-018-1021-x
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.